Xenotransplantation: Role of natural immunity

Transplant Immunology

Volumn 21, Issue 2, 2009, Pages 70-74

  Li, Shengqiao ^a   Waer, Mark ^a   Billiau, An D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Complement; Innate immune system; Macrophage; Natural immunity; Natural killer cell; Neutrophil; Xenograft rejection; Xenotransplantation

Indexed keywords

ANTIBODY;

ACUTE VASCULAR REJECTION; ADAPTIVE IMMUNITY; ALLOIMMUNITY; ARTICLE; B LYMPHOCYTE; DELAYED GRAFT FUNCTION; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE SYSTEM; IMMUNITY; INNATE IMMUNITY; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SWINE; T LYMPHOCYTE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MACROPHAGE ACTIVATION; MICE; NEUTROPHILS; PRIMATES; RATS; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRISACCHARIDES;

EID: 67349171077     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.10.004     Document Type: Article

References (100)

1. Sprangers B., Waer M., and Billiau A.D. Xenotransplantation: where are we in 2008?. Kidney Int 74 (2008) 14-21
2. Yang Y.G., and Sykes M. Xenotransplantation: current status and a perspective on the future. Nature Reviews Immunology 7 (2007) 519-531
3. Sandrin M.S., Vaughan H.A., Dabkowski P.L., and McKenzie I.F. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A 90 (1993) 11391-11395
4. Galili U., Mandrell R.E., Hamadeh R.M., Shohet S.B., and Griffiss J.M. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 56 (1988) 1730-1737
5. Lin S.S., Kooyman D.L., Daniels L.J., Daggett C.W., Parker W., Lawson J.H., et al. The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transpl Immunol 5 (1997) 212-218
6. Kobayashi T., Taniguchi S., Neethling F.A., Rose A.G., Hancock W.W., Ye Y., et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 64 (1997) 1255-1261
7. Byrne G.W., McCurry K.R., Martin M.J., McClellan S.M., Platt J.L., and Logan J.S. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63 (1997) 149-155
8. Cowan P.J., Aminian A., Barlow H., Brown A.A., Chen C.G., Fisicaro N., et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 69 (2000) 2504-2515
9. Schuurman H.J., Pino-Chavez G., Phillips M.J., Thomas L., White D.J., and Cozzi E. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors. Transplantation 73 (2002) 1146-1151
10. Loss M., Vangerow B., Schmidtko J., Kunz R., Jalali A., Arends H., et al. Acute vascular rejection is associated with systemic complement activation in a pig-to-primate kidney xenograft model. Xenotransplantation 7 (2000) 186-196
11. Vangerow B., Hecker J.M., Lorenz R., Loss M., Przemeck M., Appiah R., et al. C1-Inhibitor for treatment of acute vascular xenograft rejection in cynomolgus recipients of h-DAF transgenic porcine kidneys. Xenotransplantation 8 (2001) 266-272
12. Davis E.A., Pruitt S.K., Greene P.S., Ibrahim S., Lam T.T., Levin J.L., et al. Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts. Transplantation 62 (1996) 1018-1023
13. Fiorante P., Banz Y., Mohacsi P.J., Kappeler A., Wuillemin W.A., Macchiarini P., et al. Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models. Xenotransplantation 8 (2001) 24-35
14. Laumonier T., Mohacsi P.J., Matozan K.M., Banz Y., Haeberli A., Korchagina E.Y., et al. Endothelial cell protection by dextran sulfate: a novel strategy to prevent acute vascular rejection in xenotransplantation. Am J Transplant 4 (2004) 181-187
15. Bach F.H., Ferran C., Hechenleitner P., Mark W., Koyamada N., Miyatake T., et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3 (1997) 196-204
16. Laumonier T., Walpen A.J., Maurus C.F., Mohacsi P.J., Matozan K.M., Korchagina E.Y., et al. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells. Transplantation 76 (2003) 838-843
17. Phelps C.J., Koike C., Vaught T.D., Boone J., Wells K.D., Chen S.H., et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299 (2003) 411-414
18. Yamada K., Yazawa K., Shimizu A., Iwanaga T., Hisashi Y., Nuhn M., et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 11 (2005) 32-34
19. Kuwaki K., Tseng Y.L., Dor F.J., Shimizu A., Houser S.L., Sanderson T.M., et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 11 (2005) 29-31
20. Baumann B.C., Stussi G., Huggel K., Rieben R., and Seebach J.D. Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs. Transplantation 83 (2007) 193-201
21. Saethre M., Baumann B.C., Fung M., Seebach J.D., and Mollnes T.E. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells. Transplantation 84 (2007) 244-250
22. Taylor S.G., McKenzie I.F., and Sandrin M.S. Characterization of the rat alpha(1,3)galactosyltransferase: evidence for two independent genes encoding glycosyltransferases that synthesize Galalpha(1,3)Gal by two separate glycosylation pathways. Glycobiology 13 (2003) 327-337
23. Milland J., Christiansen D., Lazarus B.D., Taylor S.G., Xing P.X., and Sandrin M.S. The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene. J Immunol 176 (2006) 2448-2454
24. Milland J., Christiansen D., and Sandrin M.S. Alpha1,3-galactosyltransferase knockout pigs are available for xenotransplantation: are glycosyltransferases still relevant?. Immunol Cell Biol 83 (2005) 687-693
25. Sandrin M.S. Gal knockout pigs: any more carbohydrates?. Transplantation 84 (2007) 8-9
26. Ruggeri L., Aversa F., Martelli M.F., and Velardi A. Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunol Rev 214 (2006) 202-218
27. Vilches C., and Parham P. Do NK-cell receptors and alloreactivity affect solid organ transplantation?. Transpl Immunol 17 (2006) 27-30
28. Goodman D.J., von Albertini M., Willson A., Millan M.T., and Bach F.H. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 61 (1996) 763-771
29. Itescu S., Kwiatkowski P., Wang S.F., Blood T., Minanov O.P., Rose S., et al. Circulating human mononuclear cells exhibit augmented lysis of pig endothelium after activation with interleukin 2. Transplantation 62 (1996) 1927-1933
30. Malyguine A.M., Saadi S., Platt J.L., and Dawson J.R. Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers. Transplantation 61 (1996) 161-164
31. Matter-Reissmann U.B., Forte P., Schneider M.K., Filgueira L., Groscurth P., and Seebach J.D. Xenogeneic human NK cytotoxicity against porcine endothelial cells is perforin/granzyme B dependent and not inhibited by Bcl-2 overexpression. Xenotransplantation 9 (2002) 325-337
32. Lin Y., Vandeputte M., and Waer M. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 158 (1997) 5658-5667
33. Candinas D., Belliveau S., Koyamada N., Miyatake T., Hechenleitner P., Mark W., et al. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation 62 (1996) 1920-1927
34. Chen D., Weber M., Lechler R., and Dorling A. NK-cell-dependent acute xenograft rejection in the mouse heart-to-rat model. Xenotransplantation 13 (2006) 408-414
35. Itescu S., Kwiatkowski P., Artrip J.H., Wang S.F., Ankersmit J., Minanov O.P., et al. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 59 (1998) 275-286
36. Quan D., Bravery C., Chavez G., Richards A., Cruz G., Copeman L., et al. Identification, detection, and in vitro characterization of cynomolgus monkey natural killer cells in delayed xenograft rejection of hDAF transgenic porcine renal xenografts. Transplant Proc 32 (2000) 936-937
37. Inverardi L., and Pardi R. Early events in cell-mediated recognition of vascularized xenografts: cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev 141 (1994) 71-93 71-93
38. Khalfoun B., Barrat D., Watier H., Machet M.C., Arbeille-Brassart B., Riess J.G., et al. Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactions. Surgery 128 (2000) 447-457
39. Sullivan J.A., Oettinger H.F., Sachs D.H., and Edge A.S. Analysis of polymorphism in porcine MHC class I genes: alterations in signals recognized by human cytotoxic lymphocytes. J Immunol 159 (1997) 2318-2326
40. Itescu S., Artrip J.H., Kwiatkowski P.A., Wang S.F., Minanov O.P., Morgenthau A.S., et al. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products. Ann Transplant 2 (1997) 14-20
41. Kwiatkowski P., Artrip J.H., John R., Edwards N.M., Wang S.F., Michler R.E., et al. Induction of swine major histocompatibility complex class I molecules on porcine endothelium by tumor necrosis factor-alpha reduces lysis by human natural killer cells. Transplantation 67 (1999) 211-218
42. Forte P., Lilienfeld B.G., Baumann B.C., and Seebach J.D. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D. J Immunol 175 (2005) 5463-5470
43. Lilienfeld B.G., Garcia-Borges C., Crew M.D., and Seebach J.D. Porcine UL16-binding protein 1 expressed on the surface of endothelial cells triggers human NK cytotoxicity through NKG2D. J Immunol 177 (2006) 2146-2152
44. Christiansen D., Mouhtouris E., Milland J., Zingoni A., Santoni A., and Sandrin M.S. Recognition of a carbohydrate xenoepitope by human NKRP1A (CD161). Xenotransplantation 13 (2006) 440-446
45. Costa C., Barber D.F., and Fodor W.L. Human NK cell-mediated cytotoxicity triggered by CD86 and Gal alpha 1,3-Gal is inhibited in genetically modified porcine cells. J Immunol 168 (2002) 3808-3816
46. Inverardi L., Clissi B., Stolzer A.L., Bender J.R., Sandrin M.S., and Pardi R. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues. Transplantation 63 (1997) 1318-1330
47. Baumann B.C., Schneider M.K., Lilienfeld B.G., Antsiferova M.A., Rhyner D.M., Rawley R.J., et al. Endothelial cells derived from pigs lacking Gal alpha(1,3)Gal: no reduction of human leukocyte adhesion and natural killer cell cytotoxicity. Transplantation 79 (2005) 1067-1072
48. He Z., Ehrnfelt C., Kumagai-Braesch M., Islam K.B., and Holgersson J. Aberrant expression of alpha-Gal on primary human endothelium does not confer susceptibility to NK cell cytotoxicity or increased NK cell adhesion. Eur J Immunol 34 (2004) 1185-1195
49. Sheikh S., Parhar R., Kwaasi A., Collison K., Yacoub M., Stern D., et al. Alpha-gal-independent dual recognition and activation of xenogeneic endothelial cells and human naive natural killer cells. Transplantation 70 (2000) 917-928
50. Dawson J.R., Vidal A.C., and Malyguine A.M. Natural killer cell-endothelial cell interactions in xenotransplantation. Immunol Res 22 (2000) 165-176
51. Hauzenberger E., Klominek J., and Holgersson J. Anti-Gal IgG potentiates natural killer cell migration across porcine endothelium via endothelial cell activation and increased natural killer cell motility triggered by CD16 cross-linking. Eur J Immunol 34 (2004) 1154-1163
52. Rieben R., and Seebach J.D. Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. Trends Immunol 26 (2005) 2-5
53. Yin D., Zeng H., Ma L., Shen J., Xu H., Byrne G.W., et al. Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. J Immunol 172 (2004) 7235-7238
54. Simon A.R., Warrens A.N., and Sykes M. Efficacy of adhesive interactions in pig-to-human xenotransplantation. Immunol Today 20 (1999) 323-330
55. Birmele B., Thibault G., Watier H., Vallee I., Gruel Y., Nivet H., et al. Human peripheral blood lymphocyte adhesion to xenogeneic porcine aortic endothelial cells: preferential adhesion of CD3-CD16+ NK cells. Transplant Proc 26 (1994) 1150-1151
56. Schneider M.K., Forte P., and Seebach J.D. Adhesive interactions between human NK cells and porcine endothelial cells. Scand J Immunol 54 (2001) 70-75
57. Schneider M.K., Strasser M., Gilli U.O., Kocher M., Moser R., and Seebach J.D. Rolling adhesion of human NK cells to porcine endothelial cells mainly relies on CD49d-CD106 interactions. Transplantation 73 (2002) 789-796
58. Burshtyn D.N., Shin J., Stebbins C., and Long E.O. Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr Biol 10 (2000) 777-780
59. Forte P., Pazmany L., Matter-Reissmann U.B., Stussi G., Schneider M.K., and Seebach J.D. HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells. J Immunol 167 (2001) 6002-6008
60. Xu X.C., Goodman J., Sasaki H., Lowell J., and Mohanakumar T. Activation of natural killer cells and macrophages by porcine endothelial cells augments specific T-cell xenoresponse. Am J Transplant 2 (2002) 314-322
61. Li S., Yan Y., Lin Y., Bullens D.M., Rutgeerts O., Goebels J., et al. Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells. Blood 110 (2007) 3926-3935
62. Baumann B.C., Forte P., Hawley R.J., Rieben R., Schneider M.K., and Seebach J.D. Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity. J Immunol 172 (2004) 6460-6467
63. Horvath-Arcidiacono J.A., Porter C.M., and Bloom E.T. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells. Xenotransplantation 13 (2006) 318-327
64. Seebach J.D., Comrack C., Germana S., LeGuern C., Sachs D.H., and DerSimonian H. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 159 (1997) 3655-3661
65. Sasaki H., Xu X.C., and Mohanakumar T. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways. J Immunol 163 (1999) 6301-6305
66. Crew M.D., Cannon M.J., Phanavanh B., and Garcia-Borges C.N. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells. Mol Immunol 42 (2005) 1205-1214
67. Lilienfeld B.G., Crew M.D., Forte P., Baumann B.C., and Seebach J.D. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Xenotransplantation 14 (2007) 126-134
68. Crew M.D. Play it in E or G: utilization of HLA-E and -G in xenotransplantation. Xenotransplantation 14 (2007) 198-207
69. Dorling A., Monk N.J., and Lechler R.I. HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 30 (2000) 586-593
70. Kawai T., Cosimi A.B., Spitzer T.R., Tolkoff-Rubin N., Suthanthiran M., Saidman S.L., et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358 (2008) 353-361
71. Zhao Y., Ohdan H., Manilay J.O., and Sykes M. NK cell tolerance in mixed allogeneic chimeras. J Immunol 170 (2003) 5398-5405
72. Kawahara T., Rodriguez-Barbosa J.I., Zhao Y., Zhao G., and Sykes M. Global unresponsiveness as a mechanism of natural killer cell tolerance in mixed xenogeneic chimeras. Am J Transplant 7 (2007) 2090-2097
73. Hancock W.W., Blakely M.L., Van der W.W., and Bach F.H. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation. Transplant Proc 25 (1993) 2932
74. Lin Y., Vandeputte M., and Waer M. Contribution of activated macrophages to the process of delayed xenograft rejection. Transplantation 64 (1997) 1677-1683
75. Koyamada N., Sato A., Takayama J., Usuda M., Kawagishi N., Doi H., et al. Macrophage depletion prevents anti-graft antibody production and results in long-term survival in xenotransplantation. Transplant Proc 37 (2005) 514-515
76. van der Windt D.J., Bottino R., Casu A., Campanile N., and Cooper D.K. Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 14 (2007) 288-297
77. Yi S., Hawthorne W.J., Lehnert A.M., Ha H., Wong J.K., van Rooijen N., et al. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 170 (2003) 2750-2758
78. Wu G., Korsgren O., Zhang J., Song Z., van Rooijen N., and Tibell A. Pig islet xenograft rejection is markedly delayed in macrophage-depleted mice: a study in streptozotocin diabetic animals. Xenotransplantation 7 (2000) 214-220
79. Andres A., Toso C., Morel P., Bosco D., Bucher P., Oberholzer J., et al. Macrophage depletion prolongs discordant but not concordant islet xenograft survival. Transplantation 79 (2005) 543-549
80. Fox A., Mountford J., Braakhuis A., and Harrison L.C. Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection. J Immunol 166 (2001) 2133-2140
81. Fox A., Koulmanda M., Mandel T.E., van Rooijen N., and Harrison L.C. Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. Transplantation 66 (1998) 1407-1416
82. Chandra A.P., Ouyang L., Yi S., Wong J.K., Ha H., Walters S.N., et al. Chemokine and toll-like receptor signaling in macrophage mediated islet xenograft rejection. Xenotransplantation 14 (2007) 48-59
83. Yi S., Wang Y., Chandra A.P., O'Hara J.M., Wu J., Ouyang L., et al. Requirement of MyD88 for macrophage-mediated islet xenograft rejection after adoptive transfer. Transplantation 83 (2007) 615-623
84. Schmidt P., Krook H., Goto M., and Korsgren O. MyD88-dependent toll-like receptor signalling is not a requirement for fetal islet xenograft rejection in mice. Xenotransplantation 11 (2004) 347-352
85. Oldenborg P.A., Zheleznyak A., Fang Y.F., Lagenaur C.F., Gresham H.D., and Lindberg F.P. Role of CD47 as a marker of self on red blood cells. Science 288 (2000) 2051-2054
86. Takenaka K., Prasolava T.K., Wang J.C., Mortin-Toth S.M., Khalouei S., Gan O.I., et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 8 (2007) 1313-1323
87. Subramanian S., Parthasarathy R., Sen S., Boder E.T., and Discher D.E. Species- and cell type-specific interactions between CD47 and human SIRPalpha. Blood 107 (2006) 2548-2556
88. Ide K., Wang H., Tahara H., Liu J., Wang X., Asahara T., et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci U S A 104 (2007) 5062-5066 %20
89. Wang H., VerHalen J., Madariaga M.L., Xiang S., Wang S., Lan P., et al. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. Blood 109 (2007) 836-842
90. Jin R., Greenwald A., Peterson M.D., and Waddell T.K. Human monocytes recognize porcine endothelium via the interaction of galectin 3 and alpha-GAL. J Immunol 177 (2006) 1289-1295
91. McKenzie I.F., Xing P.X., Vaughan H.A., Prenzoska J., Dabkowski P.L., and Sandrin M.S. Distribution of the major xenoantigen (gal (alpha 1-3)gal) for pig to human xenografts. Transpl Immunol 2 (1994) 81-86
92. Vercellotti G.M., Platt J.L., Bach F.H., and Dalmasso A.P. Neutrophil adhesion to xenogeneic endothelium via iC3b. J Immunol 146 (1991) 730-734
93. Ehrnfelt C., Serrander L., and Holgersson J. Porcine endothelium activated by anti-alpha-GAL antibody binding mediates increased human neutrophil adhesion under flow. Transplantation 76 (2003) 1112-1119
94. Al Mohanna F., Collison K., Parhar R., Kwaasi A., Meyer B., Saleh S., et al. Activation of naive xenogeneic but not allogeneic endothelial cells by human naive neutrophils: a potential occult barrier to xenotransplantation. Am J Pathol 151 (1997) 111-120
95. al Mohanna F.A., Collison K.S., Allen S.P., Stern D., and Yacoub M.H. Naive neutrophils and xenotransplantation. Lancet 348 (1996) 1246
96. Sheikh S., Parhar R., and Al Mohanna F. Rapid static adhesion of human naive neutrophil to naive xenoendothelium under physiologic flow is independent of Galalpha1,3-gal structures. J Leukoc Biol 71 (2002) 932-940
97. Al Mohanna F., Saleh S., Parhar R.S., Khabar K., and Collison K. Human neutrophil gene expression profiling following xenogeneic encounter with porcine aortic endothelial cells: the occult role of neutrophils in xenograft rejection revealed. J Leukoc Biol 78 (2005) 51-61
98. Cardozo L.A., Rouw D.B., Ambrose L.R., Midulla M., Florey O., Haskard D.O., et al. The neutrophil: the unnoticed threat in xenotransplantation?. Transplantation 78 (2004) 1721-1728
99. Abe M., Cheng J., Qi J., Glaser R.M., Thall A.D., Sykes M., et al. Elimination of porcine hemopoietic cells by macrophages in mice. J Immunol 168 (2002) 621-628
100. Basker M., Alwayn I.P., Buhler L., Harper D., Abraham S., Kruger Gray H., et al. Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the phagocytic reticuloendothelial system in baboons. Transplantation 72 (2001) 1278-1285